Company Profile For Sun Pharmaceuticals Industries Ltd

Sun Pharmaceutical Industries Ltd. (Sun Pharma) is an international specialty pharmaceutical company. The Company’s product portfolio consists of four categories of products: India branded generics, US generics, international branded generics and active pharmaceutical ingredients (API). The products of the Company are prescribed in therapy areas like cardiology, psychiatry, neurology, gastroenterology, diabetology and respiratory. The products manufactured by the Company include Supatret, Winolap, Donamem, Exmasin, Lenzest, Octride Depot 10, Carcidox, Tyrogef, Cernos depot, Milnorm, Levipil, Exzilor and Macorate. The Company’s subsidiaries include Sun Pharma Global Inc. BVI., Sun Pharma Global-FZE, Sun Pharmaceutical (Bangladesh) Ltd., Sun Pharmaceutical Peru S.A.C. and Sun Farmaceutica Ltda-Brazil. In November 2008, the Company, along with its subsidiaries, completed the acquisition of Chattem Chemicals, Inc.

BRIEF: For the six months ended 30 September 2009, Sun Pharmaceutical Industries Limited's revenues decreased 9% to RS20.66B. Net income decreased 39% to RS6.18B. Revenues reflect a decrease in income from operations. Net income also reflects an increase in consumption of materials, higher employee costs, increased other expenditure, an increase in depreciation expenses and a decrease in gross margins of the company.

Sun Pharmaceuticals Industries Ltd
Acme Plaza
Andheri Kurla Road
Andheri (East)
Mumbai     400059
P: +9122.28211288
F: +9122.28212010

8000